Skip to main content

Table 2 Clonogenic potential of progenitors

From: Defining the molecular role of gp91phox in the immune manifestation of acute allergic asthma using a preclinical murine model

  PB/2 ml BM/2femurs LP/2lungs BAL/2lungs Spleen
WA 5371.6 ± 188.6 17034.5 ± 158.8 241.93 ± 11.8 3.15 ± 2.13 75858.9 ± 523.5
WO 16915.6 ± 219.1 57161.5 ± 161.9 11225.4 ± 155 5573.8 ± 41.6 188275.6 ± 361.1
NOXA 2343 ± 244.3 8293.3 ± 197.1 604.1 ± 125.8 59.9 ± 19.1 41774.2 ± 75.4
NOXO 9403.3 ± 382.2 40677.7 ± 220.4 6299.3 ± 195.9 5921.7 ± 41.63 219677.5 ± 426.8
DKOA 4591.6 ± 256.6 11783.1 ± 284.5 562.9 ± 183.7 32.9 ± 45.7 65974.3 ± 344.3
DKOO 9262.1 ± 342.7 41278.3 ± 361.7 7103.1 ± 201.6 6012.2 ± 59.7 197822.7 ± 388.7
  1. Decrease in clonogenic potential in bone marrow and lung of both KO mice post-OVA. CFU (Colony Forming Units) as assay was done as described in Materials and Methods and assayed in duplicate petridishes per sample. The results shown are pooled from three independent experiments (n = 5/group) ± SEM. Abbreviations used are: BM, bone marrow; PB, peripheral blood, LP, lung parenchyma, BALf, bronchoalveolar lavage fluid. The total number of progenitors was extrapolated to the total number cells obtained from each tissue. Underlined numbers denote p value < 0.01 compared to post-OVA WT.